Ran Frenkel
2014
In 2014, Ran Frenkel earned a total compensation of $6.5M as Executive Vice President, Worldwide Development Operations at Karyopharm Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $15,611 |
|---|---|
| Option Awards | $6,392,000 |
| Salary | $64,157 |
| Other | $10,097 |
| Total | $6,481,865 |
Frenkel received $6.4M in option awards, accounting for 99% of the total pay in 2014.
Frenkel also received $15.6K in non-equity incentive plan, $64.2K in salary and $10.1K in other compensation.
Rankings
In 2014, Ran Frenkel's compensation ranked 1,076th out of 13,032 executives tracked by ExecPay. In other words, Frenkel earned more than 91.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,076 out of 13,032 | 92nd |
Division Manufacturing | 391 out of 4,965 | 92nd |
Major group Chemicals And Allied Products | 129 out of 1,690 | 92nd |
Industry group Drugs | 101 out of 1,369 | 93rd |
Industry Pharmaceutical Preparations | 90 out of 1,042 | 91st |
Source: SEC filing on April 7, 2015.
Frenkel's colleagues
We found four more compensation records of executives who worked with Ran Frenkel at Karyopharm Therapeutics in 2014.